Paper36927118
Tacrolimus induces fibroblast-to-myofibroblast transition via a TGF-β-dependent mechanism to contribute to renal fibrosis.
Ume AC and 10 others. Am J Physiol Renal Physiol, 2023. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. Tacrolimus induces fibroblast-to-myofibroblast transition via a TGF-β-dependent mechanism to contribute to renal fibrosis. Papers, record 36927118. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36927118
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Myofibroblasts | Major topic |
| Tacrolimus | Major topic |
| Transforming Growth Factor beta1 | Major topic |
| Renal Insufficiency | Major topic |
| Animals | |
| Mice | |
| Actins | |
| Calcineurin Inhibitors | |
| Fibroblasts | |
| Fibrosis | |
| Mice, Inbred C57BL | |
| Receptors, Transforming Growth Factor beta |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 DK133698 | NIDDK NIH HHS | United States | R01DK133698 | PubMed and NIH | NIH RePORTER |
| F30 NS124237 | NINDS NIH HHS | United States | F30NS124237 | PubMed and NIH | NIH RePORTER |
| R21 DK119879 | NIDDK NIH HHS | United States | R21DK119879 | PubMed and NIH | NIH RePORTER |
| R01 AR077574 | NIAMS NIH HHS | United States | R01AR077574 | PubMed and NIH | NIH RePORTER |
| F30 DK130531 | NIDDK NIH HHS | United States | F30DK130531 | PubMed and NIH | NIH RePORTER |
References62
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22992590 | TGFβ signalling in context. | Nat Rev Mol Cell Biol | 2012 | https://conductscience.org/library/papers/22992590 | PubMed |
| 2 | 1693970 | Kidney transplantation under FK 506. | JAMA | 1990 | https://conductscience.org/library/papers/1693970 | PubMed |
| 3 | 15194300 | Cyclosporine versus tacrolimus in kidney transplantation: are there differences in nephrotoxicity? | Transplant Proc | 2004 | https://conductscience.org/library/papers/15194300 | PubMed |
| 4 | 12646197 | The immunosuppressive agent tacrolimus induces p21WAF/CIP1WAF1/CIP1 via TGF-beta secretion. | Biochem Biophys Res Commun | 2003 | https://conductscience.org/library/papers/12646197 | PubMed |
| 5 | 28057611 | WNT-5A regulates TGF-β-related activities in liver fibrosis. | Am J Physiol Gastrointest Liver Physiol | 2017 | https://conductscience.org/library/papers/28057611 | PubMed |
| 6 | 16709228 | TGFbeta1 induces epithelial-mesenchymal transition, but not myofibroblast transdifferentiation of human kidney tubular epithelial cells in primary culture. | Int J Exp Pathol | 2006 | https://conductscience.org/library/papers/16709228 | PubMed |
| 7 | 12135494 | Substrate selectivity and sensitivity to inhibition by FK506 and cyclosporin A of calcineurin heterodimers composed of the alpha or beta catalytic subunit. | Eur J Biochem | 2002 | https://conductscience.org/library/papers/12135494 | PubMed |
| 8 | 18349138 | FK506 can activate transforming growth factor-beta signalling in vascular smooth muscle cells and promote proliferation. | Cardiovasc Res | 2008 | https://conductscience.org/library/papers/18349138 | PubMed |
| 9 | 16049326 | Cyclosporine A-induced renal fibrosis: a role for epithelial-mesenchymal transition. | Am J Pathol | 2005 | https://conductscience.org/library/papers/16049326 | PubMed |
| 10 | 11015619 | Calcineurin: form and function. | Physiol Rev | 2000 | https://conductscience.org/library/papers/11015619 | PubMed |
| 11 | 7678785 | Anti-tumor-promoting action of FK506, a potent immunosuppressive agent. | Carcinogenesis | 1993 | https://conductscience.org/library/papers/7678785 | PubMed |
| 12 | 25404086 | Early withdrawal of calcineurin inhibitor from a sirolimus-based immunosuppression stabilizes fibrosis and the transforming growth factor-β signalling pathway in kidney transplant. | Nephrology (Carlton) | 2015 | https://conductscience.org/library/papers/25404086 | PubMed |
| 13 | 29127010 | Cyclosporine A exhibits gender-specific nephrotoxicity in rats: Effect on renal tissue inflammation. | Biochem Biophys Res Commun | 2018 | https://conductscience.org/library/papers/29127010 | PubMed |
| 14 | 33225712 | Calcineurin inhibitors: a double-edged sword. | Am J Physiol Renal Physiol | 2021 | https://conductscience.org/library/papers/33225712 | PubMed |
| 15 | 10676738 | Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future. | Am J Kidney Dis | 2000 | https://conductscience.org/library/papers/10676738 | PubMed |
| 16 | 17318077 | Loss of the alpha-isoform of calcineurin is sufficient to induce nephrotoxicity and altered expression of transforming growth factor-beta. | Transplantation | 2007 | https://conductscience.org/library/papers/17318077 | PubMed |
| 17 | 12427154 | Expression of TGF-beta and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity. | Kidney Int | 2002 | https://conductscience.org/library/papers/12427154 | PubMed |
| 18 | 10760088 | Basic fibroblast growth factor expression is increased in human renal fibrogenesis and may mediate autocrine fibroblast proliferation. | Kidney Int | 2000 | https://conductscience.org/library/papers/10760088 | PubMed |
| 19 | 29362864 | Tacrolimus-induced nephrotoxicity in mice is associated with microRNA deregulation. | Arch Toxicol | 2018 | https://conductscience.org/library/papers/29362864 | PubMed |
| 20 | 28493530 | M2 macrophages induce EMT through the TGF-β/Smad2 signaling pathway. | Cell Biol Int | 2017 | https://conductscience.org/library/papers/28493530 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42931082 | Dissociation Between Whole-Blood and Kidney Tissue Tacrolimus Exposure in Kidney Transplant Recipients. | J Xenobiot | 2026 | https://conductscience.org/library/papers/42931082 | PubMed |
| 42903463 | TGF-β in chronic kidney disease: a controversy for decades. | Front Immunol | 2026 | https://conductscience.org/library/papers/42903463 | PubMed |
| 42792805 | Calcineurin Inhibitor-Based Triple Immunosuppressive Therapy Induces Profibrotic Changes in the Jejunal Mucosa of Male Rats: A Digital Image Analysis of Collagen Fibers. | Biomedicines | 2026 | https://conductscience.org/library/papers/42792805 | PubMed |
| 42215564 | Downregulation of CXCL16/ADAM10 axis by Simvastatin attenuates tacrolimus-induced tubulointerstitial fibrosis. | Sci Rep | 2026 | https://conductscience.org/library/papers/42215564 | PubMed |
| 41815791 | The tumor microenvironment of cutaneous squamous cell carcinoma in high-risk patient groups: A scoping review. | JID Innov | 2026 | https://conductscience.org/library/papers/41815791 | PubMed |
| 41169617 | N-Acetyltransferase 2 Inhibits Myopia by Maintaining Mitochondrial Metabolism in Scleral Fibroblasts. | Research (Wash D C) | 2025 | https://conductscience.org/library/papers/41169617 | PubMed |
| 40537561 | Fibroblast activation and heterogeneity in fibrotic disease. | Nat Rev Nephrol | 2025 | https://conductscience.org/library/papers/40537561 | PubMed |
| 40508210 | Tacrolimus Modulates TGF-β Signaling-Related Genes and MicroRNAs in Human Retinal Pigment Epithelial Cells Activated by Lipopolysaccharide. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40508210 | PubMed |
| 40165930 | Deciphering the interplay: circulating cell-free DNA, signaling pathways, and disease progression in idiopathic pulmonary fibrosis. | 3 Biotech | 2025 | https://conductscience.org/library/papers/40165930 | PubMed |
| 39840315 | The safety of cyclosporine and tacrolimus in pediatric nephrotic syndrome patients: a disproportionate analysis based on the FAERS database. | Front Pediatr | 2024 | https://conductscience.org/library/papers/39840315 | PubMed |
| 38886743 | Current state of signaling pathways associated with the pathogenesis of idiopathic pulmonary fibrosis. | Respir Res | 2024 | https://conductscience.org/library/papers/38886743 | PubMed |
| 38704766 | Linagliptin ameliorates tacrolimus-induced renal injury: role of Nrf2/HO-1 and HIF-1α/CTGF/PAI-1. | Mol Biol Rep | 2024 | https://conductscience.org/library/papers/38704766 | PubMed |
| 38041193 | Cell and rat serum, urine and tissue metabolomics analysis elucidates the key pathway changes associated with chronic nephropathy and reveals the mechanism of action of rhein. | Chin Med | 2023 | https://conductscience.org/library/papers/38041193 | PubMed |
| 37759492 | Calcineurin Is a Universal Regulator of Vessel Function-Focus on Vascular Smooth Muscle Cells. | Cells | 2023 | https://conductscience.org/library/papers/37759492 | PubMed |
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| figshare | 10.6084/m9.figshare.21770534 |
Source figshare
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36927118
GET https://conductscience.org/api/papers/v1/36927118/references?page=2